Comparison of Hypothermic and Normothermic Targeted Temperature Management in Out-of-hospital Cardiac Arrest Patients with Acute Coronary Syndrome: a Nationwide Retrospective Study

Overview

Journal Crit Care

Specialty Critical Care

Date 2025 Jan 6

PMID 39762968

Authors

Tasuku Matsuyama

Bon Ohta

Makoto Watanabe

Tetsuhisa Kitamura

Affiliations

Soon will be listed here.

Abstract

Background: Targeted temperature management (TTM) is considered a beneficial treatment for improving outcomes in patients with OHCA due to acute coronary syndrome (ACS). The comparative benefits of hypothermic TTM (32-34°C) versus normothermic TTM (35-36°C) are unclear. This study compares these TTM strategies in improving neurological outcomes and survival rates in OHCA patients with ACS.

Methods: We conducted a retrospective analysis using data from the Japanese Association for Acute Medicine Out-of-Hospital Cardiac Arrest (JAAM-OHCA) registry, encompassing 68,110 OHCA patients between June 2014 and December 2020. After applying inclusion and exclusion criteria, 1,217 adult patients with ACS who received TTM were eligible for the study. Patients were categorized into two groups based on their TTM strategy: hypothermic TTM (32-34°C) and normothermic TTM (35-36°C). The primary outcome was 30-day favorable neurological outcome, defined by the Cerebral Performance Category (CPC) scale (CPC 1-2). Secondary outcomes included 30-day survival and adverse event incidence. Statistical analysis involved multivariable logistic regression and propensity score adjustments with inverse probability weighting (IPW) to account for potential confounders.

Results: Of the 1,217 patients, 369 received normothermic TTM and 848 received hypothermic TTM. In both groups, most patients were male, with a median age in the 60s. Approximately 70% had a shockable rhythm at the scene, one-third had a shockable rhythm in-hospital, around 70% had ST segment elevation, and about half received extracorporeal membrane oxygenation. The proportions of patients with 30-day favorable neurological outcomes were 36.6% (135) in the normothermic group and 36.6% (310) in the hypothermic group. No difference in neurological outcomes was observed in the multivariable regression analysis (adjusted OR 1.14, 95% CI 0.84-1.54), and the result was consistent in the IPW analysis (OR 1.11, 95% CI 0.84-1.47). Other outcomes also showed no significant differences.

Conclusion: In this nationwide, retrospective study using the JAAM-OHCA registry, we found no significant differences in 30-day favorable neurological outcome, 30-day survival, and adverse event incidences between hypothermic TTM (32-34°C) and normothermic TTM (35-36°C) in adult patients with OHCA due to ACS.

References

Polderman K . Application of therapeutic hypothermia in the intensive care unit. Opportunities and pitfalls of a promising treatment modality--Part 2: Practical aspects and side effects. Intensive Care Med. 2004; 30(5):757-69. DOI: 10.1007/s00134-003-2151-y. View

Bernard S, Gray T, Buist M, Jones B, Silvester W, Gutteridge G . Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med. 2002; 346(8):557-63. DOI: 10.1056/NEJMoa003289. View

During J, Annborn M, Cariou A, Chew M, Dankiewicz J, Friberg H . Influence of temperature management at 33 °C versus normothermia on survival in patients with vasopressor support after out-of-hospital cardiac arrest: a post hoc analysis of the TTM-2 trial. Crit Care. 2022; 26(1):231. PMC: 9339193. DOI: 10.1186/s13054-022-04107-9. View

Pound P, Ebrahim S, Sandercock P, Bracken M, Roberts I . Where is the evidence that animal research benefits humans?. BMJ. 2004; 328(7438):514-7. PMC: 351856. DOI: 10.1136/bmj.328.7438.514. View

Levy B, Girerd N, Amour J, Besnier E, Nesseler N, Helms J . Effect of Moderate Hypothermia vs Normothermia on 30-Day Mortality in Patients With Cardiogenic Shock Receiving Venoarterial Extracorporeal Membrane Oxygenation: A Randomized Clinical Trial. JAMA. 2022; 327(5):442-453. PMC: 8808325. DOI: 10.1001/jama.2021.24776. View

Kitamura T, Iwami T, Atsumi T, Endo T, Kanna T, Kuroda Y . The profile of Japanese Association for Acute Medicine - out-of-hospital cardiac arrest registry in 2014-2015. Acute Med Surg. 2018; 5(3):249-258. PMC: 6028794. DOI: 10.1002/ams2.340. View

Perkins G, Graesner J, Semeraro F, Olasveengen T, Soar J, Lott C . European Resuscitation Council Guidelines 2021: Executive summary. Resuscitation. 2021; 161:1-60. DOI: 10.1016/j.resuscitation.2021.02.003. View

Watanabe M, Matsuyama T, Miyamoto Y, Kitamura T, Komukai S, Ohta B . The impact of different targeted temperatures on out-of-hospital cardiac arrest outcomes in patients receiving extracorporeal membrane oxygenation: a nationwide cohort study. Crit Care. 2022; 26(1):380. PMC: 9733046. DOI: 10.1186/s13054-022-04256-x. View

Kern K, Lotun K, Patel N, Mooney M, Hollenbeck R, McPherson J . Outcomes of Comatose Cardiac Arrest Survivors With and Without ST-Segment Elevation Myocardial Infarction: Importance of Coronary Angiography. JACC Cardiovasc Interv. 2015; 8(8):1031-1040. DOI: 10.1016/j.jcin.2015.02.021. View

10.

Reynolds J, Grunau B, Rittenberger J, Sawyer K, Kurz M, Callaway C . Association Between Duration of Resuscitation and Favorable Outcome After Out-of-Hospital Cardiac Arrest: Implications for Prolonging or Terminating Resuscitation. Circulation. 2016; 134(25):2084-2094. PMC: 5173423. DOI: 10.1161/CIRCULATIONAHA.116.023309. View

11.

Matsuyama T, Kitamura T, Kiyohara K, Nishiyama C, Nishiuchi T, Hayashi Y . Impact of cardiopulmonary resuscitation duration on neurologically favourable outcome after out-of-hospital cardiac arrest: A population-based study in Japan. Resuscitation. 2017; 113:1-7. DOI: 10.1016/j.resuscitation.2017.01.005. View

12.

Bro-Jeppesen J, Annborn M, Hassager C, Wise M, Pelosi P, Nielsen N . Hemodynamics and vasopressor support during targeted temperature management at 33°C Versus 36°C after out-of-hospital cardiac arrest: a post hoc study of the target temperature management trial*. Crit Care Med. 2014; 43(2):318-27. DOI: 10.1097/CCM.0000000000000691. View

13.

Cui H, Yang Z, Xiao P, Shao F, Zhao S, Tang Z . Effects of Different Target Temperatures on Angiogenesis and Neurogenesis Following Resuscitation in a Porcine Model After Cardiac Arrest. Shock. 2020; 55(1):67-73. DOI: 10.1097/SHK.0000000000001559. View

14.

Nielsen N, Wetterslev J, Cronberg T, Erlinge D, Gasche Y, Hassager C . Targeted temperature management at 33°C versus 36°C after cardiac arrest. N Engl J Med. 2013; 369(23):2197-206. DOI: 10.1056/NEJMoa1310519. View

15.

Gotberg M, van der Pals J, Olivecrona G, Gotberg M, Koul S, Erlinge D . Mild hypothermia reduces acute mortality and improves hemodynamic outcome in a cardiogenic shock pig model. Resuscitation. 2010; 81(9):1190-6. DOI: 10.1016/j.resuscitation.2010.04.033. View

16.

Roberts I, Kwan I, Evans P, Haig S . Does animal experimentation inform human healthcare? Observations from a systematic review of international animal experiments on fluid resuscitation. BMJ. 2002; 324(7335):474-6. PMC: 1122396. DOI: 10.1136/bmj.324.7335.474. View

17.

Jacobs I, Nadkarni V, Bahr J, Berg R, Billi J, Bossaert L . Cardiac arrest and cardiopulmonary resuscitation outcome reports: update and simplification of the Utstein templates for resuscitation registries. A statement for healthcare professionals from a task force of the international liaison committee on.... Resuscitation. 2004; 63(3):233-49. DOI: 10.1016/j.resuscitation.2004.09.008. View

18.

Hooijmans C, De Vries R, Ritskes-Hoitinga M, Rovers M, Leeflang M, IntHout J . Facilitating healthcare decisions by assessing the certainty in the evidence from preclinical animal studies. PLoS One. 2018; 13(1):e0187271. PMC: 5764235. DOI: 10.1371/journal.pone.0187271. View

19.

Podrid P, Myerburg R . Epidemiology and stratification of risk for sudden cardiac death. Clin Cardiol. 2006; 28(11 Suppl 1):I3-11. PMC: 6653918. DOI: 10.1002/clc.4960281303. View

20.

Mak I, Evaniew N, Ghert M . Lost in translation: animal models and clinical trials in cancer treatment. Am J Transl Res. 2014; 6(2):114-8. PMC: 3902221. View